Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jun 24:12:1179547619857680.
doi: 10.1177/1179547619857680. eCollection 2019.

Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential

Affiliations
Case Reports

Secondary Leiomyosarcoma of the Lower Limb Following Uterine Smooth Muscle Tumor of Uncertain Malignant Potential

Jose María García-Sánchez et al. Clin Med Insights Case Rep. .

Abstract

Introduction: This report presents uterine smooth muscle tumors of uncertain malignant potential course with an unpredictable clinical behavior and late metastases. Metastases have been described to the humerus, lung, and peritoneum.

Case presentation: Hereby we present the case of a 71-year-old woman with a past surgical history of hysterectomy and bilateral adnexectomy due to a smooth muscle tumor of unknown malignant potential, who was evaluated 6 years later after the appearance of a mass in the proximal third of the right lower limb. The mass was diagnosed as a G1 epithelioid leiomyosarcoma and was surgically removed with immediate reconstruction with a tendinous transfer to the tibialis posterior muscle to maintain foot dorsiflexion.

Conclusion: Patients diagnosed with smooth uterine muscle tumors of uncertain malignant potential should be closely followed up given the possibility of recurrence and late metastases, bearing in mind uncommon locations as well, such as the lower limb.

Keywords: leiomyosarcoma; lower extremity; metastases; smooth muscle tumors of unknown malignant potential.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
STIR FSE coronal MRI showing a soft tissue tumor in the proximal third of the right leg with fusiform morphology. FSE indicates fast spin echo; STIR, Short-TI Inversion Recovery; MRI, magnetic resonance imaging.
Figure 2.
Figure 2.
Foot dorsiflexion motion after resection and tendinous transfer surgery.
Figure 3.
Figure 3.
Macroscopic image corresponding to the bloc, free-border resection of the tumor located in the lower limb. Tumor size 13 × 5 × 5 cm3. Pearl-colored lesion, with focal yellowish areas, that represents necrosis areas and minor read-colored areas that correspond with hemorrhage foci.
Figure 4.
Figure 4.
Hematoxylin-eosin (10×): atypical cellular proliferation of mesenchymal cells of epithelioid and fusiform morphology, disposed in a fascicular and storiform pattern.
Figure 5.
Figure 5.
Immunohistochemistry: caldesmon, actin, calponin, and desmin diffuse positive, which confirms smooth muscle origin and the diagnosis of leiomyosarcoma. Nuclear positivity to estrogen receptor suggests a metastatic gynecological origin; in this case, a STUMP. STUMP indicates smooth uterine muscle tumors of uncertain malignant potential.

References

    1. Artola Pérez de Azanza M, Navarro Echeverría L, Tejerina González E, Cristóbal García I. Tumoraciones mesenquimales de músculo liso uterino de potencial incierto: revisión anatomopatológica y pronóstica de un caso clínico. Prog Obstet Ginecol. 2013;56:418–423.
    1. Ip PPC, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010;17:91–112. - PubMed
    1. Dall’Asta A, Gizzo S, Musaro A, et al. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence. Int J Clin Exp Pathol. 2014;7:8136–8142. - PMC - PubMed
    1. Mowers EL, Skinner B, McLean K, Reynolds RK. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice. J Minim Invasive Gynecol. 2015;22:601–606. - PubMed
    1. De Vita A, Mercatali L, Miserocchi G, et al. Establishment of a primary culture of patient-derived soft tissue sarcoma. J Vis Exp. 2018;2018:e56767. - PMC - PubMed

Publication types